TKI Monotherapy Still has a Role in mRCC Front-Line Therapy - 100098

Spotlight
Video

TKI Monotherapy Still has a Role in mRCC Front-Line Therapy

kidneycancer has 473 videos Subscribe Here

Loading........
Description: Bradley A McGregor, MD Clinical Director Lank Center for Genitourinary Oncology Dana Farber Cancer Institute discusses TKI Monotherapy Still has a Role in mRCC Front-Line Therapy at the 2017 Kidney Cancer Association symposium in Miami, FL.

Shared By : kidneycancer
Posted on : 11/07/17
Added : 7 months ago
Category : Kidney Cancer



Recommended

Nothing found.